Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Not Recruiting

Trial ID: NCT00482352


This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.

Official Title

Classification Of Acute Lymphoblastic Leukemia

Stanford Investigator(s)


Inclusion Criteria:

   - Newly diagnosed acute lymphoblastic leukemia, defined by any of the following:

      - At least 25% blasts in the bone marrow

      - Absolute blast count at least 10,000/mm^3, if bone marrow aspiration is not

   - No prior registration on this study


other: laboratory biomarker analysis

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Peds Hem/Onc CRAs

New Trial Alerts

Receive email alerts when trials open to patients.